Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Cancer. 2018 May 24;124(14):3008–3015. doi: 10.1002/cncr.31405

Table 2.

Muscle radiodensity and mortality

Overall Mortality CRC Mortality
SMD
Range
At-risk Events HR Lower
bound,
95% CI
Upper
bound,
95% CI
Events HR Lower
bound, 95%
CI
Upper
bound, 95%
CI
Low SMD by sex-specific optimal stratification 879 451
  Normal 32.5 – 72.1 2296 481 259
  Low 5.7 – 35.5 966 398 1.61 1.36 1.90 192 1.74 1.38 2.21
Quartiles of SMD
  High 44.4 – 72.1 815 153 93
  Mid-High 37.7 – 47.2 816 177 0.94 0.75 1.18 89 0.94 0.68 1.28
  Mid-Low 30.8 – 41.0 816 201 0.95 0.75 1.21 109 1.10 0.79 1.53
  Low 5.7 – 34.6 815 348 1.50 1.15 1.94 160 1.63 1.13 2.36
  p for trend across quartiles 0.001 0.003
  p for trend (continuous) <0.0001 0.0001

"SMD"=skeletal muscle radiodensity (HU); HR=hazard ratio

Models simultaneously adjusted for muscle mass, visceral and subcutaneous adiposity in quartiles

Additionally adjusted for age at diagnosis (continuous), sex (ref=Male), race (ref=White), site (ref=Proximal), stage (ref=I), grade (ref=Well differentiated), chemotherapy (ref=No), radiation (ref=No), smoking history (ref=Never), comorbidity score (ref=0) and partitioned BMI (continuous)